Australian public assessment report for Nivolumab and ...

Lung cancer is the most common cancer worldwide, with 1.8 million new cases diagnosed yearly, and an estimated 1.6 million deaths worldwide. Nonsmall cell lung cancer (NSCLC) is the most common type of lung cancer (approximately 80% to 85% in Australia; ... and responded that the immunotherapy was very well tolerated for all 15 nivolumab ... ................
................